ReviewNPJ breast cancer2026
Sequencing PARP inhibitors in breast cancer: lessons learned and emerging insights.
Kenan Aloss et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
ReviewNPJ breast cancer2026
Kenan Aloss et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.